In addition to latest news on THEMIS, you can find a selection of our latest clinical risk alerts based on our claims intelligence. These are provided to help keep clinical practice reactive to emerging clinical risk trends, ensuring we can help create a safer clinical world.
THEMIS’ Lead Clinical Partner, TMLEP, discusses the vital importance of carrying out appropriate investigations such as an OGD when a Patient is suffering from reoccurring symptoms to rule out any sinister causes such as cancer.
THEMIS’ Lead Clinical Partner, TMLEP, talks to their Member Dr Jacob de Wolff about life on the front line during the COVID-19 pandemic.
In this Clinical Risk Update, THEMIS’ Clinical Partner, TMLEP, would like to highlight the importance of correctly reporting inadequate and therefore inconclusive smear test results.
In this Clinical Risk Alert, THEMIS’ Lead Clinical Partner, TMLEP highlights that Lisfranc injuries are uncommon and can be difficult to diagnose which can put patients at risk of unnecessary harm and clinicians at risk for potential claims. This guidance is designed to help improve patient safety, reduce the possibility of misdiagnosis, and the risk of potential litigation.
In this Clinical Risk Alert, THEMIS’ Lead Clinical Partner, TMLEP, would like to emphasise clinicians need to have a lower threshold for further investigation/admission to hospital for possible appendicitis in children.
Soft tissue injuries can be severe and can have greater implications for future function, if neglected, than many fractures that would be routinely referred for specialist orthopaedic assessment.
By offering policyholders complimentary access to the very latest healthcare analytics updates from TMLEP, policyholders are kept up to date with access to clinical risk alerts that may impact their practice. As a THEMIS policyholder, this keeps clinical practice responsive to emerging trends that could lead to claims.